The antihypertensive drugs market will register a CAGR of over 2% by 2023

Wednesday, March 20, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, March 19, 2019 /PRNewswire/ -- About this marketPatients with hypertension are generally treated with drugs

that can reduce blood volume (reducing central venous pressure and cardiac output), reduce systemic vascular resistance, and reduce cardiac output by depressing heart rate and stroke volume. For instance, diuretic drugs decrease the blood volume by increasing
urine output by the kidney. Similarly, vasodilator drugs dilate blood vessels through the relaxation of smooth muscle in blood vessels. Cardioinhibitory drugs depress cardiac function by decreasing heart rate, myocardial contractility, or both, which decreases cardiac output and arterial pressure. Hence, the availability of a wide range of therapeutics is offering specific treatment to the patients with hypertension and driving the growth of the global antihypertensive drugs market during the forecast period. Analysts have predicted that the antihypertensive drugs market will register a CAGR of over 2% by 2023.Read the full report: https://www.reportlinker.com/p05756623/?utm_source=PRN Market OverviewRising population with risk factors of hypertensionSome medical conditions can raise the risk of high blood pressure. The growing prevalence of diabetes increases the risk of development of hypertension. Hence, an increase in the number of people with these risk factors is expected to increase the number of people with hypertension. This, in turn, is expected to aid in the use of available drugs, which will drive the growth of the global antihypertensive drugs market during the forecast period.Increasing generics popularityGeneric medicines contain the same active ingredient in the same quantity as a branded medicine. The development of generic drugs is simple and less time-taking. Therefore, the launch of generic drugs with lesser price than the innovator drugs is diluting and deceleration the market growth and is expected to hamper the growth of the market during our forecast period.For the detailed list of factors that will drive and challenge the growth of the antihypertensive drugs market during the 2019-2023, view our report.Competitive LandscapeThe market appears to be moderately fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.Read the full report: https://www.reportlinker.com/p05756623/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-antihypertensive-drugs-market-will-register-a-cagr-of-over-2-by-2023-300814990.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store